Aker BioMarine, Lindsay Goldberg to Form 50/50 Joint Venture

An affiliate of Lindsay Goldberg LLC ("LG" or "Lindsay Goldberg")—a New York-based private investment firm with approximately USD 10 billion of equity capital under management and a long-term investment horizon of up to 20 years—has entered into an agreement with Aker BioMarine ASA ("AKBM" or "Aker BioMarine") to acquire 50% of all outstanding shares in a newly established joint venture company ("NewCo") that will own Trygg Pharma AS and Natural Nutrition Development Ltd AS ("NND"), both wholly owned subsidiaries of Aker BioMarine.

Lindsay Goldberg will pay up to NOK 280 million for the 50% stake in NewCo, of which NOK 140 million is paid upfront and another NOK 140 million is subject to certain development milestones.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.